0.78
+0.0102(+1.33%)
Currency In USD
| Previous Close | 0.77 |
| Open | 0.79 |
| Day High | 0.82 |
| Day Low | 0.77 |
| 52-Week High | 2.2 |
| 52-Week Low | 0.7 |
| Volume | 76,233 |
| Average Volume | 797,835 |
| Market Cap | 38.2M |
| PE | -0.96 |
| EPS | -0.81 |
| Moving Average 50 Days | 0.88 |
| Moving Average 200 Days | 1.15 |
| Change | 0.01 |
If you invested $1000 in PDS Biotechnology Corporation (PDSB) 10 years ago, it would be worth $3.15 as of January 02, 2026 at a share price of $0.78. Whereas If you bought $1000 worth of PDS Biotechnology Corporation (PDSB) shares 5 years ago, it would be worth $342.11 as of January 02, 2026 at a share price of $0.78.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
PDS Biotech Announces New Composition of Matter Patent for PDS0101 in Japan
GlobeNewswire Inc.
Dec 09, 2025 1:00 PM GMT
New Patent Grants Broad Composition Claims for PDS0101 Previously Granted Patent Protections and Anticipated Market Exclusivity Provide Protection for PDS0101 in the United States into the 2040s PRINCETON, N.J., Dec. 09, 2025 (GLOBE NEWSWIRE) -- PD
PDS Biotech Announces Scheduling of Type C Meeting with U.S. Food and Drug Administration (“FDA”)
GlobeNewswire Inc.
Dec 02, 2025 1:30 PM GMT
Company to Discuss Proposed Amendment to Phase 3 VERSATILE-003 Trial Enabling Potential Accelerated Approval PathwayPRINCETON, N.J., Dec. 02, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a
PDS Biotechnology Announces up to $11.1 Million Registered Direct Offering
GlobeNewswire Inc.
Nov 11, 2025 8:31 PM GMT
$5.3 million Upfront with up to an Additional $5.8 million of Aggregate Gross Proceeds upon the Cash Exercise in Full of WarrantsPRINCETON, N.J., Nov. 11, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “